Creating a new weapon in the fight against malaria

Over 200 million people contract malaria each year, and according to the World Health Organization, an estimated 655,000 people died from malaria in 2010.

Malaria is caused by the parasite Plasmodium, which is transmitted to humans through mosquito bites. More effective control of malaria will require the development of to prevent new infections.

Wesley Van Voorhis at the University of Washington in Seattle and Oliver Billker at the Wellcome Trust Sanger Institute in Cambridge, England assembled an international research team to tackle the challenge of finding new ways to combat malaria.

Their unique approach was to uncover a pathway that could block transmission of Plasmodium from humans to mosquitos, which represents a new strategy for controlling the spread of malaria.

They discovered a new class of malaria transmission-blocking compounds that work by inhibiting a protein known as bumped kinase I. Bumped kinase I is required for Plasmodium to transition to sporozoites stage, the stage in its life cycle when it is infectious to mammals. In that fed on blood treated with the bumped kinase inhibitor, Plasmodium sporozoite formation was blocked.

The research team showed preclinical data in mice indicating that bumped kinase inhibitors are safe and well tolerated.

Their results show that bumped kinase inhibitors target a new life cycle stage in Plasmodium, and suggest that these compounds merit further development as a new therapy for .

More information: www.jci.org/articles/view/6182… bd73a892f008d6fa9cae

add to favorites email to friend print save as pdf

Related Stories

Slamming the brakes on the malaria life cycle

Feb 23, 2012

Scientists have discovered a new target in their fight against the devastating global disease 'malaria' thanks to the discovery of a new protein involved in the parasite's life cycle.

Recommended for you

A hybrid vehicle that delivers DNA

19 hours ago

A new hybrid vehicle is under development. Its performance isn't measured by the distance it travels, but rather the delivery of its cargo: vaccines that contain genetically engineered DNA to fight HIV, cancer, ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.